Cargando…
Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique
OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficien...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823167/ https://www.ncbi.nlm.nih.gov/pubmed/35155777 http://dx.doi.org/10.1002/lio2.713 |
_version_ | 1784646745973587968 |
---|---|
author | Hassan, Charles‐Henri Malheiro, Emeline Béquignon, Emilie Coste, André Bartier, Sophie |
author_facet | Hassan, Charles‐Henri Malheiro, Emeline Béquignon, Emilie Coste, André Bartier, Sophie |
author_sort | Hassan, Charles‐Henri |
collection | PubMed |
description | OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication. METHODS: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS. RESULTS: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications. CONCLUSION: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS. Level of evidence: 4. |
format | Online Article Text |
id | pubmed-8823167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88231672022-02-11 Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique Hassan, Charles‐Henri Malheiro, Emeline Béquignon, Emilie Coste, André Bartier, Sophie Laryngoscope Investig Otolaryngol Allergy, Rhinology, and Immunology OBJECTIVES: Atrophic rhinitis (AR) and empty nose syndrome (ENS) are chronic diseases characterized by a paradoxical nasal obstruction. These rare syndromes tend to occur after nasal surgery of the inferior turbinates in ENS and can be idiopathic in AR. Medical treatments alone are often insufficient. Surgical options are challenging and numerous resorbable and nonresorbable implants have been described in small series, with as many surgical techniques described. Whereas current surgical procedures are for risk of extrusions, graft rejections or poor lasting results, the use of GlassBONE™ (Sodimed®, Avignon, France), a bioactive glass, for a vestibular approach in AR and ENS has never been reported for this indication. METHODS: We described an original technique of nasal submucoperiosteal bilateral ceramic glass implantation in two patients with AR and ENS. RESULTS: The two cases presented a postoperative satisfying endoscopic and sinus CT‐scan results with filling of the nasal cavities, with less crusts and a complete wound healing. They had no short‐term complications. CONCLUSION: This innovative approach is easily feasible and could be an option considered for the surgical management of AR and ENS. Level of evidence: 4. John Wiley & Sons, Inc. 2021-12-08 /pmc/articles/PMC8823167/ /pubmed/35155777 http://dx.doi.org/10.1002/lio2.713 Text en © 2021 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Allergy, Rhinology, and Immunology Hassan, Charles‐Henri Malheiro, Emeline Béquignon, Emilie Coste, André Bartier, Sophie Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title | Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title_full | Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title_fullStr | Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title_full_unstemmed | Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title_short | Sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: Operative technique |
title_sort | sublabial bioactive glass implantation for the management of primary atrophic rhinitis and empty nose syndrome: operative technique |
topic | Allergy, Rhinology, and Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823167/ https://www.ncbi.nlm.nih.gov/pubmed/35155777 http://dx.doi.org/10.1002/lio2.713 |
work_keys_str_mv | AT hassancharleshenri sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique AT malheiroemeline sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique AT bequignonemilie sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique AT costeandre sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique AT bartiersophie sublabialbioactiveglassimplantationforthemanagementofprimaryatrophicrhinitisandemptynosesyndromeoperativetechnique |